Editorial: Impact of emerging treatment modalities on stromal cells in the tumour microenvironment

• Haiyang Wu,
• Haiyang Wu,
• Dietrich Alexander Ruess,
• Dietrich Alexander Ruess,
• Jinxue Zhou,
• Haitao Zhao

Affiliations

Haiyang Wu

Department of Orthopaedics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China

Haiyang Wu

Department of Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, China

Dietrich Alexander Ruess

Department of General and Visceral Surgery, Center for Surgery, Medical Center University of Freiburg, Freiburg, Germany

Dietrich Alexander Ruess

German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany

Jinxue Zhou

Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Tumor Hospital of Zhengzhou University, Zhengzhou, China

Haitao Zhao

Department of Liver Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS & PUMC), Beijing, China